PEAK6 Investments’s Pulmonx LUNG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-19,809
Closed -$253K 4436
2023
Q4
$253K Buy
19,809
+6,800
+52% +$70.8K ﹤0.01% 3086
2023
Q3
$134K Sell
13,009
-4,137
-24% -$47.9K ﹤0.01% 3278
2023
Q2
$225K Buy
+17,146
New +$210K ﹤0.01% 2793
2022
Q3
Sell
-17,146
Closed -$225K 5619
2022
Q2
$225K Buy
+17,146
New +$353K ﹤0.01% 4656

Other funds holding LUNG

PEAK6 Investments's LUNG Position: Q1 2024 in Review

PEAK6 Investments sold out of Pulmonx (LUNG) in Q1 2024, closing a stake of 19,809 shares — an estimated $253K sold.

PEAK6 Investments first reported a position in LUNG in Q2 2022 and held it in 4 quarters. The position peaked at $253K in Q4 2023. 118 funds tracked by Wall St. Rank hold LUNG as of Q1 2024.

  • PEAK6 Investments reported no remaining Pulmonx position as of Q1 2024 after selling out during the quarter.
  • PEAK6 Investments sold 19,809 Pulmonx shares in Q1 2024, an estimated $253K.
  • PEAK6 Investments first reported a position in Pulmonx in Q2 2022 and held it in 4 quarters.
  • PEAK6 Investments's Pulmonx position peaked at $253K in Q4 2023.
  • 118 funds tracked by Wall St. Rank held Pulmonx as of Q1 2024.

Based on PEAK6 Investments's 13F filing for Q1 2024, filed 14 May 2024.